An exploratory clinical trial on the efficacy and safety of glucagon-like peptide-1 receptor agonist dulaglutide in patients with type 2 diabetes on maintenance hemodialysis

Overview of attention for article published in Renal Replacement Therapy, June 2022

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 14 Mendeley

So far, Altmetric has seen 1 X post from an account with 145 followers.

宇賀村大亮先生の論文「An exploratory clinical trial on the efficacy and safety of glucagon-like peptide-1 receptor agonist dulaglutide in patients with type 2 diabetes on maintenance hemodialysis」がRenal Replacement Therapyに掲載されました。 https://t.co/X3uMzrhwmD

28 Oct 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.